Cerebrospinal fluid IL-8 levels reflect symptoms of alexithymia in patients with non-inflammatory neurological disorders

Psychoneuroendocrinology

Volumn 36, Issue 8, 2011, Pages 1148-1153

  Uher, Tomas ^a,b   Bob, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

Author keywords

Alexithymia; Anxiety; Cerebrospinal fluid; Cytokines; Inflammation; Interleukin 8

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; ALBUMIN BLOOD LEVEL; ALEXITHYMIA; ANTIBODY BLOOD LEVEL; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; NEUROLOGIC DISEASE; NONINFLAMMATORY NEUROLOGIC DISORDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PSYCHOMETRY; SYMPTOMATOLOGY;

ADULT; AFFECTIVE SYMPTOMS; ANXIETY; C-REACTIVE PROTEIN; ENCEPHALITIS; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 80051550003     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.02.006     Document Type: Article

References (41)

1. Bagby R.M., Taylor G.J., Parker J.D. The twenty-item Toronto Alexithymia Scale-II. Convergent, discriminant, and concurrent validity. J. Psychosom. Res. 1994, 38(1):33-40.
2. Bagby R.M., Taylor G.J. Affect dysregulation and alexithymia. Disorders of Affect Regulation: Alexithymia in Medical and Psychiatric Illness 1997, 26-45. University Press, Cambridge. G.J. Taylor, R.M. Bagby, J.D.A. Parker (Eds.).
3. Baggiolini M., Loetscher P., Moser B. Interleukin-8 and the chemokine family. Int. J. Immunopharmacol. 1995, 17:103-108.
4. Beck A.T., Steer R.A., Brown G.K. Manula for Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio, TX.
5. Bob P. Pain, dissociation and subliminal self-representations. Conscious. Cogn. 2008, 17:355-369.
6. Bruni R., Serino F.M., Galluzzo S., Coppolino G., Cacciapaglia F., Vadacca M., Nilo S., Terminio N., Afeltra A. Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-alpha levels. Ann. N. Y. Acad. Sci. 2006, 1069:208-211.
7. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 1995, 332:595-638.
8. Corcos M., Guilbaud O., Paterniti S., Curt F., Hjalmarsson L., Moussa M., Chambry J., Loas G., Chaouat G., Jeammet P. Correlation between serum levels of interleukin-4 and alexithymia scores in healthy female subjects: preliminary findings. Psychoneuroendocrinology 2004, 29(4):557-562.
9. De Gucht V., Heiser W. Alexithymia and somatisation: quantitative review of the literature. J. Psychosom. Res. 2003, 54:425-434.
10. De Timary P., Roy E., Luminet O., Fille C., Mikolajczak M. Relationship between alexithymia, alexithymia factors and salivary cortisol in men exposed to a social stress test. Psychoneuroendocrinology 2008, 33(8):1160-1164.
11. Dewaraja R., Tanigawa T., Araki S., Nakata A., Kawamura N., Ago Y., Sasaki Y. Decreased cytotoxic lymphocyte counts in alexithymia. Psychother. Psychosom. 1997, 66(2):83-86.
12. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 2000, 52(4):595-638.
13. Elenkov I.J., Chrousos G.P. Stress Hormones, proinflammantory and antiinflammantory cytokines, and autoimmunity. Ann. N. Y. Acad. Sci. 2002, 966:290-303.
14. Elenkov I.J. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem. Int. 2008, 52(1-2):40-51.
15. Finset A., Graugaard P.K., Holgersen K. Salivary cortisol response after a medical interview: the impact of physician communication behaviour, depressed affect and alexithymia. Patient Educ. Couns. 2006, 60(2):115-124.
16. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.-C., Yoshida M., Ding H.A., Gimbrone M.A., Luster A.D., Luscinckas F.W., Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398:718-723.
17. Guilbaud O., Corcos M., Hjalmarsson L., Loas G., Jeammet P. Is there a psychoneuroimmuno-logical pathway between alexithymia and immunity? Immune and physiological correlates of alexithymia. Biomed. Pharmacother. 2003, 57(7):292-295.
18. Guilbaud O., Curt F., Perrin C., Chaouat G., Berthoz S., Dugré-Le Bigre C., Wallier J., Strebler M., Touitou C., Jeammet P., Corcos M. Decreased immune response in alexithymic women: a cross-sectional study. Biomed. Pharmacother. 2009, 63(4):297-304.
19. Hoge E.A., Brandstetter K., Moshier S., Pollack M.H., Wong K.K., Simon N.M. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress. Anxiety 2009, 26(5):447-455.
20. Kiecolt-Glasser J.K., McGuire L., Nobles T.F., Laser R. Psychoneuroimmunology and psychosomatic medicine: back to the future. Psychosom. Med. 2002, 64:15-28.
21. Lehto S.M., Niskanen L., Herzig K.H., Tolmunen T., Huotari A., Viinamäki H., Koivumaa-Honkanen H., Honkalampi K., Ruotsalainen H., Hintikka J. Serum chemokine levels in major depressive disorder. Psychoneuroendocrinology 2010, 35(2):226-232.
22. Lucinio J., Wong M.L., Gold P.W. Neutrophil-activating peptide-1/interleukin-8 mRNA is localized in rat hypothalamus and hippocampus. Neuroreport 1992, 3(9):753-756.
23. Lin S., Zhao S.F., Yan F.H. The influence of alexithymia in stress on secretory IgA and cortisol in saliva. Shanghai Kou Qiang Yi Xue 2005, 14(6):561-564.
24. Lindholm T., Lehtinen V., Hyyppä M.T., Puukka P. Alexithymic features in relation to the dexamethasone suppression test in a Finnish population sample. Am. J. Psychiatry 1990, 147(9):1216-1219.
25. Locatelli V., Bresciani E., Tamiazzo L., Torsello A. Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function. Endocr. Dev. 2010, 17:108-120.
26. Marques A.H., Silverman M.N., Sternberg E.M. Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics. Ann. N. Y. Acad. Sci. 2009, 1179:1-18.
27. Mattila A.K., Salminen J.K., Nummi T., Joukamaa M. Age is strongly associated with alexithymia in the general population. J. Psychosom. Res. 2006, 61(5):629-635.
28. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 24(388 (6640)):394-397.
29. Moriguchi Y., Maeda M., Igarashi T., Ishikawa T., Shoji M., Kubo C., Komaki G. Age and gender effect on alexithymia in large, Japanese community and clinical samples: a cross-validation study of the Toronto Alexithymia Scale (TAS-20). Biopsychosoc. Med. 2007, 1:7.
30. Pasini A., Delle Chiaie R., Seripa S., Ciani N. Alexithymia as related to sex, age, and educational level: results of the Toronto Alexithymia Scale in 417 normal subjects. Compr. Psychiatry 1992, 33(1):42-46.
31. Pedrosa, Gil F., Nickel M., Ridout N., Schwarz M.J., Schoechlin C., Schmidmaier R. Alexithymia and interleukin variations in somatoform disorder. Neuroimmunomodulation 2007, 14(5):235-242.
32. Porcelli P., Bagby R.M., Taylor G.J., De Carne M., Leandro G., Todarello O. Alexithymia as predictor of treatment outcome in patients with functional gastrointestinal disorders. Psychosom. Med. 2003, 65(5):911-918.
33. Rostène W., Guyon A., Kular L., Godefroy D., Barbieri F., Bajetto A., Banisadr G., Callewaere C., Conductier G., Rovère C., Mélik-Parsadaniantz S., Florio T. Chemokines and chemokine receptors: New actors in neuroendocrine regulations. Front. Neuroendocrinol. 2010, 10.1016/j.yfrne.2010.07.001.
34. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The mini-international neuropsychiatric interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33.
35. Todarello O., Casamassima A., Marinaccio M., La Pesa M.W., Caradonna L., Valentino L., Marinaccio L. Alexithymia, immunity and cervical intraepithelial neoplasia: a pilot study. Psychother. Psychosom. 1994, 61(3-4):199-204.
36. Todarello O., Casamassima A., Daniele S., Marinaccio M., Fanciullo F., Valentino L., Tedesco N., Wiesel S., Simone G., Marinaccio L. Alexithymia, immunity and cervical intraepithelial neoplasia: replication. Psychother. Psychosom. 1997, 66(4):208-213.
37. Uher T. Alexithymia and immune dysregulation: a critical review. Acti. Nerv. Sup. 2010, 52(1):40-44.
38. Vadacca M., Bruni R., Cacciapaglia F., Serino F., Arcarese L., Buzzulini F., Coppolino G., Rigon A., Terminio N., Afeltra A. Alexithymia and immunoendocrine parameters in patients affected by systemic lupus erythematosus and rheumatoid arthritis. Reumatismo 2008, 60(1):50-56.
39. Weik U., Herforth A., Kolb-Bachofen V., Deinzer R. Acute stress induces proinflammatory signaling at chronic inflammation sites. Psychosom. Med. 2008, 70:906-912.
40. Zarković M., Ignjatović S., Dajak M., Cirić J., Beles-lin B., Savić S., Stojković M., Bulat P., Trbojević B. Cortisol response to ACTH stimulation correlates with blood interleukin 6 concentration in healthy humans. Eur. J. Endocrinol. 2008, 159(5):649-652.
41. Zung W.W.K. A rating instrument for anxiety disorders. Psychosomatics 1971, 12:371-379.